Board of Directors
| Name…………………….. | Designation……………………….. | Short Description | |
|---|---|---|---|
 | Stéphane Thiroloix | Founder, President & CEO | HEC. Board Member at Jellagen. Prev CEO Mayoly-Spindler, EVP Europe Smith&Nephew, EVP Corporate Development IPSEN. |
 | Olivier Bohuon | Co-Founder | Chairman of the Board Majorelle. Board Member Takeda, Virbac, Reckitt. |
 | Thibaut Roulon | Member, BOD | Senior Investment Director – Life Sciences, Bpifrance. Graduate Ecole Centrale Paris, PhD in Molecular Biophysics P&M Curie University. |
 | Guillaume Blavier | Member, BOD | Associate at Omnes Capital. PharmD Rouen University, MS Audencia |
 | Hugues Le Bret | Member, BOD | Founder & Supervisory Board President Compte-Nickel. Adviser to CEO BNP Paribas. Prev President & CEO Boursorama. |
 | Scott Byrd | Independent Member, BOD | CEO Pioneer Tx, CoB of Acacia Pharma Group. BS in mechanical eng. & MBA Harvard University. |
 | Ed Harrigan | Independent Member, BOD | Board Mb at Acadia, Incyte and Phase Bio. Sc Advisor to Alzheon and Karuna Tx. BA St Anselm, MD Massachusetts University, Neurology Boston University. |
Executive Team
| Name…………………….. | Designation…………………….. | Short Description | |
|---|---|---|---|
| Stéphane Thiroloix | Founder, President & CEO | HEC. Board Member at Jellagen. Prev CEO Mayoly-Spindler, EVP Europe Smith&Nephew, EVP Corporate Development IPSEN. |
 | Philippe Picaut | Chief Development Officer | Pharm D, MSc Tox, MSc Anatomopathology, American Board of Toxicology. Sr VP Neurosciences R&D, Ipsen. |
 | Gabriel Fox | Chief Medical Officer | MD. Postgrad Dip Mktg. CMO, Acacia Pharma. Int Med Leader and Head, Gbl Onc Mktg, Roche. Med Dir, NeXstar/Gilead. |
 | Agathe Nadolny | Chief Project Mgt Officer | MSc, PMP®. Chief Project Management Officer. Previously New Pdt Plng Mgr Mayoly-Spindler, PMO Mgr Bio-Rad. |
 | France Catus | Clinical Operations Manager | MD. Statistics DIU (Cesam). Ipsen Medical Dvt Dir, Clin Dvt Dir. |
 | Julie Leibreich | Clinical Operation Project Manager | Bio. Sc., Clinical Research. Clinical Project Mgt certification. Clinical Project Mgr Medday Pharma |
 | Steve Scott | US Regulatory Officer | Founder, PDR for Pharma. Ipsen VP North American Reg Aff,Biomeasure, Pharma Dvt Resources, Sepracor, Parexel, Interferon Sciences. |
 | Etienne Bienfait | Finance & Admin Manager | Engineer, Research Master in Business Mgt. Covage, Bryan Garnier. |
Scientific Advisory Board
| Name…………………….. | Designation…………. | Short Description | |
|---|---|---|---|
 | Céline Greco | Chair, SAB | MD PhD. Hosp. Practitioner, Dpt of neonatal, pediatric & adult pain and palliative medicine, Hop Necker Enfants Malades, Paris, France. |
 | Guido Cavaletti | Member, SAB | MD. Prof Neurology, San Gerardo Hosp, Monza. BoD of Peripheral Nerve Society, Chair of Toxic Neuropathy Consortium, Intl Peri-Noms group in CIPN. |
 | David Cornblath | Member, SAB | MD. Prof Neurology, Johns Hopkins. BoD of Peripheral Nerve Society, BoD Foundation for Peripheral Neuropathy. |
 | Jean Deregnaucourt | Member, SAB | DVM, Post Doc UCLA. Ex RPR, Pierre Fabre R&D, Dir Biotech French Min. Research, Research Apps Institut Pasteur. |
 | Roy Freeman | Member, SAB | MD. Prof Neurology, Harvard Med School. Dir Cntr for Autonomic and Periph Nerve Disorders at Beth Israel Deaconess Medical Ctr, Boston, Ma. |
 | Axel Le Cesne | Member, SAB | Assoc Prof of Medicine. Head of Medical Onclogy Hospital Unit, Gustave Roussy, France. |
 | Curtis Rosebraugh | Member, SAB | MD, Ex CDER Director Office of Drug Evaluation II : DPARP, DMEP & Div of Anesthesia, Analgesia & Addiction Products. |